Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Clinicopathological Features and Molecular Typing of Invasive Fibroma of Abdominal Wall and Construction of Recurrence Risk Model

NCT06204198 is registered in ClinicalTrials.gov with Shandong Provincial Hospital as lead sponsor.

NCT NCT06204198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06204198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Clinicopathological Features and Molecular Typing of Invasive Fibroma of Abdominal Wall and Construction of Recurrence Risk Model
Lead sponsor
Shandong Provincial Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2023
Completion date
September 1, 2024
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aggressive fibromatosis of abdominal wall (disorder)